Modification by AZ-55, guanethidine and bretylium of responses of atria and aortic strips to transmural stimulation.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001011:Aorta / Q000187:drug effects / Q000502:physiology*; D001949:Bretylium Compounds / Q000494:pharmacology*; D003042:Cocaine / Q000494:pharmacology; D003864:Depression, Chemical; D004558:Electric Stimulation; D005260:Female; D006145:Guanethidine / Q000494:pharmacology*; D006146:Guanidines / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D012849:Sinoatrial Node / Q000187:drug effects / Q000502:physiology*; D014105:Tosyl Compounds / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D006146:Guanidines; D014105:Tosyl Compounds; D003042:Cocaine; D009638:Norepinephrine; D014439:Tyramine; D006145:Guanethidine